rs2238087

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate

The NM_000719.7(CACNA1C):​c.1114-292C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000751 in 1,332,062 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.5e-7 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 intron

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.556

Publications

11 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Orphanet
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: ClinGen, Orphanet
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 12-2504550-C-G is Benign according to our data. Variant chr12-2504550-C-G is described in ClinVar as Likely_benign. ClinVar VariationId is 512978.Status of the report is criteria_provided_single_submitter, 1 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000719.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1C
NM_000719.7
MANE Select
c.1114-292C>G
intron
N/ANP_000710.5
CACNA1C
NM_001167623.2
MANE Plus Clinical
c.1217+11C>G
intron
N/ANP_001161095.1Q13936-37
CACNA1C
NM_199460.4
c.1114-292C>G
intron
N/ANP_955630.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1C
ENST00000399603.6
TSL:5 MANE Plus Clinical
c.1217+11C>G
intron
N/AENSP00000382512.1Q13936-37
CACNA1C
ENST00000399655.6
TSL:1 MANE Select
c.1114-292C>G
intron
N/AENSP00000382563.1Q13936-12
CACNA1C
ENST00000682544.1
c.1204-292C>G
intron
N/AENSP00000507184.1A0A804HIR0

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
7.51e-7
AC:
1
AN:
1332062
Hom.:
0
Cov.:
21
AF XY:
0.00000149
AC XY:
1
AN XY:
670084
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30956
American (AMR)
AF:
0.00
AC:
0
AN:
44526
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25396
East Asian (EAS)
AF:
0.0000256
AC:
1
AN:
39072
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83692
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53230
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5506
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
993556
Other (OTH)
AF:
0.00
AC:
0
AN:
56128
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
7.4
DANN
Benign
0.73
PhyloP100
-0.56
PromoterAI
-0.0094
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2238087; hg19: chr12-2613716; API